1. Home
  2. VINC vs JAGX Comparison

VINC vs JAGX Comparison

Compare VINC & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VINC
  • JAGX
  • Stock Information
  • Founded
  • VINC 2019
  • JAGX 2013
  • Country
  • VINC United States
  • JAGX United States
  • Employees
  • VINC N/A
  • JAGX N/A
  • Industry
  • VINC Biotechnology: Pharmaceutical Preparations
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VINC Health Care
  • JAGX Health Care
  • Exchange
  • VINC Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • VINC 10.7M
  • JAGX 9.6M
  • IPO Year
  • VINC N/A
  • JAGX N/A
  • Fundamental
  • Price
  • VINC $0.30
  • JAGX $0.97
  • Analyst Decision
  • VINC Buy
  • JAGX
  • Analyst Count
  • VINC 2
  • JAGX 0
  • Target Price
  • VINC $2.00
  • JAGX N/A
  • AVG Volume (30 Days)
  • VINC 354.0K
  • JAGX 304.8K
  • Earning Date
  • VINC 11-12-2024
  • JAGX 11-13-2024
  • Dividend Yield
  • VINC N/A
  • JAGX N/A
  • EPS Growth
  • VINC N/A
  • JAGX N/A
  • EPS
  • VINC N/A
  • JAGX N/A
  • Revenue
  • VINC N/A
  • JAGX $10,480,000.00
  • Revenue This Year
  • VINC N/A
  • JAGX $32.33
  • Revenue Next Year
  • VINC N/A
  • JAGX $43.63
  • P/E Ratio
  • VINC N/A
  • JAGX N/A
  • Revenue Growth
  • VINC N/A
  • JAGX N/A
  • 52 Week Low
  • VINC $0.29
  • JAGX $0.90
  • 52 Week High
  • VINC $9.37
  • JAGX $30.84
  • Technical
  • Relative Strength Index (RSI)
  • VINC 28.28
  • JAGX 40.43
  • Support Level
  • VINC $0.29
  • JAGX $0.95
  • Resistance Level
  • VINC $0.38
  • JAGX $1.20
  • Average True Range (ATR)
  • VINC 0.03
  • JAGX 0.09
  • MACD
  • VINC 0.01
  • JAGX -0.00
  • Stochastic Oscillator
  • VINC 7.00
  • JAGX 23.40

About VINC Vincerx Pharma Inc.

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: